Can semaglutide 0.5 mg cause chest discomfort, tachycardia, and shortness of breath during brisk walking?
Tirzepatide, a dual GIP/GLP-1 receptor agonist, has shown even greater efficacy in some studies, with weight reductions of approximately 20% in the SURMOUNT-1 trial
Cecilia Scott focuses on helping you understand how the treatment works, what to expect during the first few weeks, and how to prepare your body with proper hydration and balanced nutrition for a smooth start
Understanding Semaglutide Semaglutide is an FDA-approved GLP-1 receptor agonist effective for long-term weight management in adults with obesity or those overweight with a related health condition
Modulation of gut microbiota by foods and herbs to prevent cardiovascular diseases
Every plan is directed by John Bergeron, MD, and prepared by a personally vetted, Texas state licensed 503A pharmacy